Hemanth J. Varghese is the Chief Strategy Officer of Viatris. He joined the company in April 2025.
Hemanth is an accomplished healthcare leader with more than 20 years of strategy, operations and corporate development experience. He brings broad experience leading growth initiatives and strategic transformations in diversified multi-national healthcare companies. He has successfully completed more than 50 strategic business development, M&A and complex business transformation initiatives valued at more than $35 billion.
Prior to joining Viatris, he was President and Chief Operating Officer at Venus Concept, an innovative global medical aesthetic technology company.
Hemanth previously served as Senior Vice President, Strategy & Operations at HLS Therapeutics. He also held multiple roles at Endo International, including Executive Vice President, Corporate Development & Strategy and President, International Pharmaceuticals, several roles of increasing responsibility at Valeant Pharmaceuticals and Bausch & Lomb and worked in corporate development at Biovail Corporation.
Hemanth earned a bachelor’s degree and a Ph.D. in medical biophysics from the University of Western Ontario in Ontario, Canada. He is also a Chartered Financial Analyst.
This person is not in any teams
This person is not in any offices
Viatris
39 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.